Delivery Order SPE2DB22D3011-SPE2DB25FP7NP

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,230.48 firm fixed-price delivery order is for the supply of 100-count units of 50 mg sertraline hydrochloride tablets, a common antidepressant medication. The contract has a ceiling value of $1,230.48 and an ultimate completion date of March 20, 2024. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,831.16, is for the delivery of 4567615431 Sertraline HCL 100 mg tablets. This is a Firm Fixed Price Delivery Order contract with a completion date of March 19, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,019.64 firm-fixed-price delivery order is for the supply of 4,568,190,588 units of the medication sertraline hydrochloride 100 mg tablets. The contract has a performance period extending through May 9, 2025 and is not set aside for any socioeconomic category. AmerisourceBergen Drug Corp holds a substantial...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,061,527 units of the prescription medication Sertraline HCL 50 mg tablets. The firm-fixed-price delivery order, valued at $1,434.95, has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award, valued at $1,399.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567584990 SERTRALINE HCL 100 MG TABLET 500S, with an ultimate completion date of March 17, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $7,994.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,964,022 units of Sertraline HCL 50 mg tablets, a common antidepressant medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp is the prime contractor...
This federal contract award, valued at $1,931.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sertraline HCL 50 mg tablets. The contract has an ultimate completion date of May 24, 2023. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,011.16, is for the delivery of 4,567,860 tablets of Sertraline HCL 25 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 10, 2025. Amerisourcebergen is the prime contractor on this award and has no set-aside designation, indicating it was an open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.64 firm fixed-price delivery order is for the supply of 4,556,391,802 units of Sertraline HCL 100 mg tablets. The contract has no set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
This federal contract award, valued at $2,627.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567629455 SERTRALINE HCL 50 MG TABLET 500S, a pharmaceutical product, with a performance period through March 20, 2025. The contract has a Firm Fixed Price pricing type and does not utilize any set-aside designation. Amerisourcebergen holds a...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP7NP
    Delivery Order

This is a $1,085.40 federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order for the supply of 500 count bottles of 100 mg Sertraline HCL tablets. The contract has an ultimate completion date of October 31, 2024 and is a Firm Fixed Price arrangement.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award appears to be issued against that overarching IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:47 PM